Human HIN-1/SCGB3A1 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF2790
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
E. coli-derived recombinant human HIN‑1/SCGB3A1
Phe21-Gly104
Accession # Q96QR1
Phe21-Gly104
Accession # Q96QR1
Specificity
Detects human HIN‑1/SCGB3A1 in direct ELISAs and Western blots. In Western blots, approximately 10% cross-reactivity with recombinant mouse HIN-1 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Human HIN-1/SCGB3A1 Antibody
Application
Recommended Usage
Western Blot
0.1 µg/mL
Sample: Recombinant Human HIN-1/SCGB3A1
Sample: Recombinant Human HIN-1/SCGB3A1
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Reviewed Applications
Read 1 review rated 5 using AF2790 in the following applications:
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: HIN-1/SCGB3A1
Long Name
High in Normal 1
Alternate Names
HIN1, PnSP-2, SCGB3A1, UGRP2
Gene Symbol
SCGB3A1
UniProt
Additional HIN-1/SCGB3A1 Products
Product Documents for Human HIN-1/SCGB3A1 Antibody
Product Specific Notices for Human HIN-1/SCGB3A1 Antibody
For research use only
Loading...
Loading...
Loading...
Loading...